Skip to main content
OpenTrials

Clinical trial condition

Head and Neck Neoplasms

Explore clinical trials studying Head and Neck Neoplasms. Study availability and eligibility vary by location and protocol.

183 public trials 28 recruiting studies
Refine in advanced search Browse all conditions

Head and Neck Neoplasms trial results

Active, Not Recruiting

Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)

NCT03765918

Conditions
Head and Neck Neoplasms, Neoplasms, Neoplasms by Site, +1 more
Locations
  • Moores Cancer Center ( Site 1885) La Jolla, California, United States
  • University of Southern California Norris Comprehensive Cancer Center ( Site 1850) Los Angeles, California, United States
  • Hoag Memoriall Hospital Presbyterian ( Site 2056) Newport Beach, California, United States
  • UC Davis Health System ( Site 1864) Sacramento, California, United States
View all 192 locations
View Trial Details
Active, Not Recruiting

A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2

NCT06003231

Conditions
Adnexal Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +24 more
Locations
  • Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers Chandler, Arizona, United States
  • Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers Gilbert, Arizona, United States
  • Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers Glendale, Arizona, United States
  • Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers Mesa, Arizona, United States
View all 96 locations
View Trial Details
Active, Not Recruiting

First in Human Study of AZD9592 in Solid Tumors

NCT05647122

Conditions
Advanced Solid Tumours, Bronchial Neoplasms, Carcinoma Non-small Cell Lung, +19 more
Locations
  • Research Site Duarte, California, United States
  • Research Site North Haven, Connecticut, United States
  • Research Site Washington D.C., District of Columbia, United States
  • Research Site Chicago, Illinois, United States
View all 46 locations
View Trial Details
Active, Not Recruiting

Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)

NCT02568267

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Adnexal Diseases, +91 more
Locations
  • Dignity Health St Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • City of Hope Cancer Center Duarte, California, United States
  • City of Hope Duarte - Comprehensive Cancer Center, Investigational Drug Services Duarte, California, United States
View all 130 locations
View Trial Details

Related conditions